Cargando…
Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic Drugs
[Image: see text] We describe the design and optimization of polyfunctional scaffolds based on a fluorescent indolizine core derivatized with various orthogonal groups (amines, esters, oximes, alkynes, etc.). To show one application as tools in biology, the scaffold was used to prepare drug–biotin c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044919/ https://www.ncbi.nlm.nih.gov/pubmed/30023604 http://dx.doi.org/10.1021/acsomega.7b01184 |
_version_ | 1783339572672856064 |
---|---|
author | Arvin-Berod, Marie Desroches-Castan, Agnès Bonte, Simon Brugière, Sabine Couté, Yohann Guyon, Laurent Feige, Jean-Jacques Baussanne, Isabelle Demeunynck, Martine |
author_facet | Arvin-Berod, Marie Desroches-Castan, Agnès Bonte, Simon Brugière, Sabine Couté, Yohann Guyon, Laurent Feige, Jean-Jacques Baussanne, Isabelle Demeunynck, Martine |
author_sort | Arvin-Berod, Marie |
collection | PubMed |
description | [Image: see text] We describe the design and optimization of polyfunctional scaffolds based on a fluorescent indolizine core derivatized with various orthogonal groups (amines, esters, oximes, alkynes, etc.). To show one application as tools in biology, the scaffold was used to prepare drug–biotin conjugates that were then immobilized onto avidin-agarose for affinity chromatography. More specifically, the antiangiogenic drug COB223, whose mechanism of action remained unclear, was chosen as a proof-of-concept drug. The drug-selective discrimination of proteins observed after elution of the cell lysates through the affinity columns, functionalized either with the biologically active COB223 or a structurally related inactive analogue (COB236), is a clear indication that the presence of the indolizine core does not limit drug–protein interaction and confirms the usefulness of the indolizine scaffold. Furthermore, the separation of COB223-interacting proteins from human placental extracts unveiled unanticipated protein targets belonging to the family of regulatory RNA-binding proteins, which opens the way to new hypotheses on the mode of action of this antiangiogenic drug. |
format | Online Article Text |
id | pubmed-6044919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-60449192018-07-16 Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic Drugs Arvin-Berod, Marie Desroches-Castan, Agnès Bonte, Simon Brugière, Sabine Couté, Yohann Guyon, Laurent Feige, Jean-Jacques Baussanne, Isabelle Demeunynck, Martine ACS Omega [Image: see text] We describe the design and optimization of polyfunctional scaffolds based on a fluorescent indolizine core derivatized with various orthogonal groups (amines, esters, oximes, alkynes, etc.). To show one application as tools in biology, the scaffold was used to prepare drug–biotin conjugates that were then immobilized onto avidin-agarose for affinity chromatography. More specifically, the antiangiogenic drug COB223, whose mechanism of action remained unclear, was chosen as a proof-of-concept drug. The drug-selective discrimination of proteins observed after elution of the cell lysates through the affinity columns, functionalized either with the biologically active COB223 or a structurally related inactive analogue (COB236), is a clear indication that the presence of the indolizine core does not limit drug–protein interaction and confirms the usefulness of the indolizine scaffold. Furthermore, the separation of COB223-interacting proteins from human placental extracts unveiled unanticipated protein targets belonging to the family of regulatory RNA-binding proteins, which opens the way to new hypotheses on the mode of action of this antiangiogenic drug. American Chemical Society 2017-12-27 /pmc/articles/PMC6044919/ /pubmed/30023604 http://dx.doi.org/10.1021/acsomega.7b01184 Text en Copyright © 2017 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Arvin-Berod, Marie Desroches-Castan, Agnès Bonte, Simon Brugière, Sabine Couté, Yohann Guyon, Laurent Feige, Jean-Jacques Baussanne, Isabelle Demeunynck, Martine Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic Drugs |
title | Indolizine-Based Scaffolds as Efficient and Versatile
Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic
Drugs |
title_full | Indolizine-Based Scaffolds as Efficient and Versatile
Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic
Drugs |
title_fullStr | Indolizine-Based Scaffolds as Efficient and Versatile
Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic
Drugs |
title_full_unstemmed | Indolizine-Based Scaffolds as Efficient and Versatile
Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic
Drugs |
title_short | Indolizine-Based Scaffolds as Efficient and Versatile
Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic
Drugs |
title_sort | indolizine-based scaffolds as efficient and versatile
tools: application to the synthesis of biotin-tagged antiangiogenic
drugs |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044919/ https://www.ncbi.nlm.nih.gov/pubmed/30023604 http://dx.doi.org/10.1021/acsomega.7b01184 |
work_keys_str_mv | AT arvinberodmarie indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT desrochescastanagnes indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT bontesimon indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT brugieresabine indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT couteyohann indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT guyonlaurent indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT feigejeanjacques indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT baussanneisabelle indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs AT demeunynckmartine indolizinebasedscaffoldsasefficientandversatiletoolsapplicationtothesynthesisofbiotintaggedantiangiogenicdrugs |